Clinical trial
The Treatment of Glabellar Frown Lines
NCT02096081 is registered in ClinicalTrials.gov with Merz North America, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Treatment of Glabellar Frown Lines
- Lead sponsor
- Merz North America, Inc.
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 28, 2014
- Completion date
- November 30, 2014
- Enrollment
- 250 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
glabellar frown lines